Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Cell Metabolism of groundbreaking preclinical data demonstrating ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

The Corsair Sabre v2 Pro Wireless CF takes the winning Sabre v2 Pro formula and adds a touch of premium carbon fiber, but not ...

Blake Mycoskie, founder of TOMS Shoes, has launched ENOUGH, a new lifestyle brand that is fully owned by a nonprofit with a ...

New research reveals that exercise may reprogram heart-controlling nerves, giving hope for potentially better treatments for ...

Tiny, sun-powered organisms found in freshwater pools could soon fuel Hawaiʻi's sustainable future. Researchers at the ...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

TangGene names former GSK SVP Catherine Sohn as Senior Strategic Advisor, strengthening leadership as it advances a first-in-class in-vivo CD8⁺ Treg therapy. TangGene’s in-vivo CD8⁺ Treg approach has ...

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain’s support cells ...

Cyberarchy #2 hits stores this Wednesday! A paradise planet with reanimation facilities and killer bugs. What could possibly ...